is compounded semaglutide being taken off the market Despite FDA ruling, GLP-1s are still giving Novo and Lilly headaches on Compound semaglutide not working: why
Description
These are typically the first signs of Semaglutides GLP-1 effectiveness and may be accompanied by early signs of weight loss
the broader obesity trial (TRIUMPH-1) has not yet reported, so the 28.7% headline is from a single trial in a specific group rather than a generalizable population estimate
doi: 10.1038/npp.2010.105 120 LiY.PerryT.KindyM
This article contains affiliate links, and a commission may be earned if a purchase is made through those links
Not licensed for weight loss
Typical weekly range: 2.515 mg once weekly (gradual 4week titration steps)
